Insider · CIK 0001873796
Karimah Es Sabar
Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing Apr 1, 2026, latest Apr 3, 2026.
In brief
Karimah Es Sabar files SEC Form 4 as director at CAPR (CAPRICOR THERAPEUTICS, INC.). Since Apr 1, 2026, Karimah Es Sabar has reported 0 open-market buys worth $0 and 2 open-market sells worth $3.8M, the latest filed on Apr 3, 2026.
A track record needs three past buys with six months of prices behind them; Karimah Es Sabar has 0, so none is measured yet.
The newest scored trade: sold $241k of CAPR on Apr 2, 2026, filed Apr 3, 2026, scored 28 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $3.8M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAPR: CAPRICOR THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | CAPRICOR THERAPEUTICS, INC. | $241k 7,529 shares | -100% | +598% from low-4% from high | |
| 40Moderate | CAPRICOR THERAPEUTICS, INC. | $3.5M 115,000 shares | -188% | +561% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2026 | CAPR CAPRICOR THERAPEUTICS INC | 7,529 0.01% of outstanding | $227k | Apr 2, 2026 | $3.5M |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | 115,000 0.20% of outstanding | $3.2M | Mar 31, 2026 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +7,529 | $3.18 | $24k | 7,529 | Apr 3, 2026 |
| Apr 2, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,529 | $32.00 | $241k | 0 | Apr 3, 2026 |
| Apr 2, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,529 | $0.00 | $0 | 161 | Apr 3, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +61,265 | $4.86 | $298k | 61,265 | Apr 1, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -61,265 | $30.17 | $1.8M | 0 | Apr 1, 2026 |
| Apr 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +53,735 | $4.86 | $261k | 53,735 | Apr 1, 2026 |
| Apr 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -53,735 | $31.03 | $1.7M | 0 | Apr 1, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -61,265 | $0.00 | $0 | 53,735 | Apr 1, 2026 |
| Apr 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -53,735 | $0.00 | $0 | 0 | Apr 1, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +15,500 | $0.00 | $0 | 15,500 | Jan 7, 2026 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +11,940 | $0.00 | $0 | 11,940 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +2,520 | $0.00 | $0 | 2,520 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,750 | $0.00 | $0 | 5,750 | Jan 6, 2025 |
Questions about Karimah Es Sabar
Answered from the filings on this page, as of the latest one.
Is Karimah Es Sabar buying or selling?
In the last 12 months Karimah Es Sabar reported 0 open-market buys worth $0 and 2 open-market sells worth $3.8M on SEC Form 4; the latest was sold $241k of CAPR on Apr 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Karimah Es Sabar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karimah Es Sabar has 0.
Where does Karimah Es Sabar file Form 4?
Karimah Es Sabar has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.